Search

everythinglearnresearchcommunity

for

Search:↓

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

People with Alopecia Areata often have lower vitamin D levels, and vitamin D supplements might help treat it.

Platelet rich plasma is an effective treatment for alopecia areata.

Stopping the antidepressant agomelatine improved hair loss in a patient.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Nutrient antioxidants helped reduce prednisolone dosage and improved hair growth in alopecia areata patients.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Ginger extract helps hair growth and reduces the need for prednisolone in alopecia areata patients.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Alopecia areata causes patchy hair loss and involves immune system disruptions.

A man had both alopecia areata and lichen planus, which is uncommon.

Both Betasalic ointment and 5% minoxidil are effective and safe for treating Alopecia Areata.

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

A genetic marker linked to a type of hair loss was found in most patients studied.